As a shareholder, I am STILL waiting for the BOD and the

New Post Public Reply Private Reply Replies (1) Message Board
plutonium fufat #3388
435
As a shareholder, I am STILL waiting for the BOD and the CEO to begin to create value for their shareholders. Yes its the BOD job to create value for the company which in turn their shareholders.

So another fellow who believes its all about share price. Step on up fufat. Come on in and run the company, or become Chairman and hire a new CEO. The existing BOD and CEO just suck. Of all the trader bulls**t I read on the message boards, yours won tonight's prize.

" If the company is relying on a litigation win to fund the production of new products then I don't know what to say."

You obviously believe it or you wouldn't have written the words. So, show me any evidence that you have that this is true? Any evidence that the company isn't working its tail off against great odds to raise money (that they are constantly condemned for), to create innovative new products (that they are constantly condemned for) to open new markets (that they are constantly condemned for). If you and the other message board geniuses can do better either step up or retire your keyboard. There was never a better time.

But you know what, the $50+ million they are going to get from J&J will be nice and make DECN a legend. But what the he!!, let's tell the company to drop the suit and concentrate on share price. What do you think the damn share price will be if they trounce J&J? Many who condemn will never know, because they either never owned shares, or sold years ago, or are looking to sell now. Where do you fall in?

Time to step up. Show us how a stock jockey can run a company better than an expert in the field. I have always wanted a message board poster to take over a public company. It is sort of an intellectual curiosity for me. If you read the message boards you can only come to one conclusion. Individual shareholders all know better than the current management and BOD, despite the fact that these men got here by being huge successes in their fields. This field. Every damn management and BOD decision is second guessed or worse. Well, step up and show us. And if the share price doesn't go up ... if shareholder value isn't recognized.... I can't wait to trash you.
1

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading